OnDosis Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.56M

  • Investors
  • 9

OnDosis General Information

Description

Developer of a personalized medicine device intended to improve how patients manage and take medications. The company offers a dosage manager supporting flexible delivery of pellets, granules, mini tablets, and powders with integrated digital technologies and IoT connectivity, enabling patients and healthcare providers to achieve precise dosing and enhanced treatment management.

Contact Information

Website
www.ondosis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gemenskapens gata 9
  • Pepparedsleden 1
  • 431 53 Molndal
  • Sweden
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Other Devices and Supplies
Pharmaceuticals
Therapeutic Devices
Monitoring Equipment
Other Healthcare Technology Systems
Corporate Office
  • Gemenskapens gata 9
  • Pepparedsleden 1
  • 431 53 Molndal
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OnDosis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 11-Jul-2025 $5.56M Completed Product Development
4. Later Stage VC (Series C) 04-May-2022 Completed Startup
3. Early Stage VC (Series B) 24-May-2021 Completed Startup
2. Early Stage VC (Series A) 11-Sep-2020 $3.44M $8.09M Completed Startup
1. Seed Round 01-Jan-2019 $4.65M $4.65M Completed Startup
To view OnDosis’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

OnDosis Patents

OnDosis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202410048-D0 Cloud computing and medicament dispenser Inactive 10-Jul-2024
WO-2026013222-A1 Cloud computing and medicament dispenser Pending 10-Jul-2024
EP-4743046-A1 Delivery device for medicament Pending 13-Jul-2023
GB-202310788-D0 Delivery device for medicament Inactive 13-Jul-2023
WO-2025012463-A1 Delivery device for medicament Inactive 13-Jul-2023 A61J1/03
To view OnDosis’s complete patent history, request access »

OnDosis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OnDosis Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alsteron Family Office Minority
Rydgruppen Venture Capital Minority
Aeternum Capital (UK) Asset Manager Minority
Albonja Venture Capital Minority
Boston Consulting Group Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

OnDosis FAQs

  • When was OnDosis founded?

    OnDosis was founded in 2017.

  • Where is OnDosis headquartered?

    OnDosis is headquartered in Molndal, Sweden.

  • What is the size of OnDosis?

    OnDosis has 20 total employees.

  • What industry is OnDosis in?

    OnDosis’s primary industry is Biotechnology.

  • Is OnDosis a private or public company?

    OnDosis is a Private company.

  • What is OnDosis’s current revenue?

    The current revenue for OnDosis is .

  • How much funding has OnDosis raised over time?

    OnDosis has raised $32.4M.

  • Who are OnDosis’s investors?

    Alsteron, Rydgruppen, Aeternum Capital (UK), Albonja, and Boston Consulting Group are 5 of 9 investors who have invested in OnDosis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process